<h1 id="md-ai-powered-personalized-medicine-platform">140509_49.md — AI-Powered Personalized Medicine Platform</h1>
<blockquote>
<p><strong>Theme:</strong> AI for Industry, Responsible AI<br />
<strong>Mission:</strong> Integrate genomic (DNA/RNA), clinical (EHR), and lifestyle (wearables, SDoH) data to deliver safe, explainable, privacy-preserving personalized treatment recommendations and drug discovery insights.</p>
</blockquote>
<hr />
<h2 id="readme-problem-statement">README (Problem Statement)</h2>
<p><strong>Summary:</strong> Build a platform that integrates genomic data, medical records, and lifestyle information to provide personalized treatment recommendations and drug discovery insights.<br />
<strong>Problem Statement:</strong> Precision medicine requires harmonizing heterogeneous, multi-modal data and generating evidence-based recommendations while ensuring safety, fairness, and regulatory compliance. Create a system that predicts drug response, adverse reactions, and matches patients to trials, with robust privacy.</p>
<p><strong>Steps:</strong><br />
- Multi-modal data integration (genomic + EHR + lifestyle)<br />
- Drug response prediction models<br />
- Adverse reaction prediction &amp; DDI analysis<br />
- Evidence-based treatment recommendation engine<br />
- Clinical trial matching &amp; patient stratification<br />
- Privacy-preserving analytics &amp; regulatory compliance</p>
<p><strong>Suggested Data:</strong> TCGA/ICGC genomics, UK Biobank, MIMIC-III/IV (de-identified EHR), FAERS (adverse events), DrugBank/ChEMBL, wearable datasets, clinical guidelines.</p>
<hr />
<h2 id="vision-scope-kpis">1) Vision, Scope, KPIs</h2>
<p><strong>Vision:</strong> A trustworthy, clinician-centered platform that accelerates precision care, reduces adverse events, and supports ethical AI in healthcare.<br />
<strong>Scope:</strong><br />
- v1: ETL + harmonization, baseline drug-response model, ADR risk stratification, clinician UI.<br />
- v2: trial matching, DDI engine, explainability &amp; rationale, reporting.<br />
- v3: federated analytics across hospitals, on-device options, RWE feedback loop.</p>
<p><strong>KPIs:</strong><br />
- Drug-response AUC ≥ 0.85 on held-out cohorts<br />
- ADR model AUC ≥ 0.90; NPV ≥ 0.95 for high-risk flags<br />
- Time-to-trial-match ↓ 70%<br />
- Clinician acceptance of recommendations ≥ 75%</p>
<hr />
<h2 id="personas-user-stories">2) Personas &amp; User Stories</h2>
<ul>
<li><strong>Oncologist/Cardiologist:</strong> Wants interpretable, guideline-concordant recommendations.<br />
</li>
<li><strong>Clinical Pharmacist:</strong> Needs DDI/PGx insights (CYP variants).<br />
</li>
<li><strong>Research Coordinator:</strong> Wants eligible patient lists for trials.<br />
</li>
<li><strong>Patient:</strong> Expects privacy and understandable justifications.<br />
</li>
<li><strong>Compliance Officer:</strong> Requires auditability and consent management.</li>
</ul>
<p><strong>Stories:</strong><br />
- US‑01: As a clinician, I upload VCF + EHR to get therapy ranking with genomic rationales.<br />
- US‑05: As a pharmacist, I check DDI and PGx contraindications before prescribing.<br />
- US‑09: As a coordinator, I get trial candidates by eligibility (biomarkers, ECOG).</p>
<hr />
<h2 id="prd-capabilities">3) PRD (Capabilities)</h2>
<ol type="1">
<li><strong>Data Integration &amp; Harmonization:</strong> FHIR/HL7 ingestion; VCF/FASTQ; wearable APIs; SDoH; normalize to OMOP CDM + patient-centric schema.<br />
</li>
<li><strong>Drug Response Prediction:</strong> Multi-task models using genomics (variants, expression), labs, phenotypes.<br />
</li>
<li><strong>Adverse Reaction &amp; DDI:</strong> Predict ADR probability and drug–drug/drug–gene interactions; PGx knowledge (CPIC).<br />
</li>
<li><strong>Recommendation Engine:</strong> Evidence-based ranker blending ML predictions with guidelines (NCCN/CPG), contraindications, patient prefs.<br />
</li>
<li><strong>Trial Matching:</strong> NLP parser of inclusion/exclusion; match and rank by distance to criteria; cohort builder.<br />
</li>
<li><strong>Explainability &amp; Rationale:</strong> SHAP/PERT/attention maps; guideline citations; genomic variant evidence.<br />
</li>
<li><strong>Privacy &amp; Compliance:</strong> Consent registry, de-ID, encryption, access controls, audit trails; federated learning.<br />
</li>
<li><strong>Clinician UX:</strong> Case timeline, what-if simulations, printable summaries.</li>
</ol>
<hr />
<h2 id="frd-functional-requirements">4) FRD (Functional Requirements)</h2>
<ul>
<li><strong>ETL:</strong> VCF to annotated variants (ClinVar, gnomAD); FHIR resources (Observation, Medication, Condition, Procedure); wearable time-series resampling.<br />
</li>
<li><strong>Feature Store:</strong> patient embeddings (genotype, phenotype, labs, vitals), treatment history, outcomes; temporal windows.<br />
</li>
<li><strong>Models:</strong> drug-response (per-drug head); ADR classifier; DDI graph model (drug–drug–gene).<br />
</li>
<li><strong>Recommender:</strong> constrained optimizer combining efficacy, safety, guideline weights, patient prefs, costs.<br />
</li>
<li><strong>Trial NLP:</strong> BERT-based criterion extraction; code eligibility functions.<br />
</li>
<li><strong>Cohort Ops:</strong> filter by ICD/SNOMED, variants (e.g., EGFR L858R), lab thresholds; export to REDCap/CTMS.<br />
</li>
<li><strong>Explainability:</strong> patient-specific SHAP, variant annotations, literature snippets.<br />
</li>
<li><strong>Reporting:</strong> PDF/HL7 messages; audit logs of decisions.</li>
</ul>
<hr />
<h2 id="nfrd">5) NFRD</h2>
<ul>
<li><strong>Latency:</strong> case query ≤ 2 s P95; batch scoring overnight.<br />
</li>
<li><strong>Reliability:</strong> 99.9% availability; graceful degradation offline.<br />
</li>
<li><strong>Privacy/Security:</strong> AES‑256 at rest, TLS 1.3, PHI masking, break-glass with dual approval.<br />
</li>
<li><strong>Compliance:</strong> HIPAA, GDPR, 21 CFR Part 11; model change management (GxP).<br />
</li>
<li><strong>Fairness:</strong> disparate impact monitoring; subgroup performance floors.</li>
</ul>
<hr />
<h2 id="architecture-logical">6) Architecture (Logical)</h2>
<pre><code>[Hospitals/EHR] [Genomics Labs] [Wearables] [SDoH]
     |              |             |          |
     v              v             v          v
            [ETL + De-ID + Consent Manager]
                         |
                         v
                    [Data Lake]
                         |
                         v
                  [Feature Store]
                         |
                         v
        [Models: Response | ADR | DDI Graph]
                         |
                         v
      [Recommendation/Trial Matching Engine]
                         |
                         v
             [Clinician UX + Explainability]
                         |
                         v
             [Audit/Compliance + Federated]</code></pre>
<hr />
<h2 id="hld-key-components">7) HLD (Key Components)</h2>
<ul>
<li><strong>ETL Pipelines:</strong> airflow/nifi; HGVS normalization; sample QC metrics; ICD/CPT/SNOMED mapping.<br />
</li>
<li><strong>Feature Store:</strong> Feast; time-aware joins; survival/longitudinal features.<br />
</li>
<li><strong>Drug Response:</strong> transformer encoders for variants + clinical; survival head for time-to-progression.<br />
</li>
<li><strong>ADR/PGx:</strong> model + knowledge graphs (CPIC/PharmGKB) for drug–gene rules.<br />
</li>
<li><strong>DDI Graph:</strong> hetero-GNN on drug–drug–gene edges; predict interaction severity.<br />
</li>
<li><strong>Trial NLP:</strong> criteria parser → boolean DSL; fuzzy tolerance ranges.<br />
</li>
<li><strong>Recommender:</strong> multi-objective (efficacy, safety, QoL, cost); constraints for allergies, pregnancy, renal/hepatic function.<br />
</li>
<li><strong>Explainability:</strong> local SHAP; variant evidence cards; cite guidelines.<br />
</li>
<li><strong>Federated Learning:</strong> TensorFlow Federated/Flower; secure aggregation.</li>
</ul>
<hr />
<h2 id="lld-selected">8) LLD (Selected)</h2>
<p><strong>ADR Risk Calculation:</strong><br />
<code>risk_total = w1*model_prob + w2*DDI_score + w3*PGx_rule + w4*history_flag</code></p>
<p><strong>Eligibility Function Example:</strong><br />
- <code>age &gt;= 18 AND ECOG in {0,1} AND EGFR_L858R == true AND creatinine_clearance &gt;= 50</code></p>
<p><strong>Recommender Objective:</strong><br />
Maximize <code>U = α*Efficacy − β*ADR − γ*Cost + δ*PreferenceMatch</code>, subject to contraindications and DDI hard constraints.</p>
<hr />
<h2 id="pseudocode-patient-flow">9) Pseudocode (Patient Flow)</h2>
<pre class="pseudo"><code>patient = harmonize(FHIR, VCF, wearables)
X = featurize(patient)
resp = model_response(X)
adr = model_adr(X)
ddi = gnn_ddi(patient.meds, patient.genotype)
recs = optimize(resp, adr, ddi, guidelines, prefs)
trials = match_trials(patient, protocols)
return report(recs, trials, explanations)</code></pre>
<hr />
<h2 id="data-evaluation">10) Data &amp; Evaluation</h2>
<ul>
<li><strong>Datasets:</strong> TCGA, UK Biobank (where licensed), MIMIC-IV, FAERS, DrugBank, CPIC, clinical guidelines.<br />
</li>
<li><strong>Metrics:</strong> AUC/PR, calibration (ECE), NNT/NNH simulations, trial-matching precision/recall, time-to-decision.<br />
</li>
<li><strong>Validation:</strong> temporal holdouts; clinician review panels; post-market real-world evidence.</li>
</ul>
<hr />
<h2 id="security-privacy-governance">11) Security, Privacy, Governance</h2>
<ul>
<li>Consent management; DUA enforcement; k-anonymity for exports; DP for analytics; immutable audit.<br />
</li>
<li>RBAC/ABAC; PHI tokenization; key custody/HSMs; BAA with vendors.</li>
</ul>
<hr />
<h2 id="observability-cost">12) Observability &amp; Cost</h2>
<ul>
<li>Metrics: query latency, model drift, alert rates, subgroup perf; audit lead time.<br />
</li>
<li>Cost: tiered storage, GPU batch windows, quantized inference; federated to minimize data movement.</li>
</ul>
<hr />
<h2 id="roadmap">13) Roadmap</h2>
<ul>
<li><strong>M1 (4w):</strong> ETL + baseline models + clinician UI.<br />
</li>
<li><strong>M2 (8w):</strong> ADR/DDI + explanations + trial matching.<br />
</li>
<li><strong>M3 (12w):</strong> Federated analytics + RWE loop.<br />
</li>
<li><strong>M4 (16w):</strong> Regulatory reports + on-device pilots.</li>
</ul>
<hr />
<h2 id="risks-mitigations">14) Risks &amp; Mitigations</h2>
<ul>
<li><strong>Bias &amp; fairness:</strong> subgroup audits, reweighting, clinician oversight.<br />
</li>
<li><strong>Data sparsity:</strong> transfer learning, imputation, uncertainty estimates.<br />
</li>
<li><strong>Clinical liability:</strong> decision support (not decision making), explainability, override workflows.<br />
</li>
<li><strong>Privacy breaches:</strong> strict access, DP/federation, continuous monitoring.</li>
</ul>
